Quarterly report [Sections 13 or 15(d)]

Consolidated Balance Sheets

v3.25.3
Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 4,512 $ 13,199
Marketable securities 48,628 82,376
Total Current Assets 53,140 95,575
Total Assets 53,140 95,575
Current Liabilities    
Accounts payable and accrued expenses 959,797 780,148
Derivative Liability 3,297,695
Total Current Liabilities 8,728,825 5,166,681
Total Liabilities 8,728,825 5,166,681
Stockholders’ Deficit    
Common stock, $0.0001 par value: authorized 500,000,000, 22,454,264 and 21,674,000 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 2,245 2,167
Additional paid-in capital 952,603 810,048
Accumulated deficit (9,630,533) (5,883,321)
Total Stockholders’ Deficit (8,675,685) (5,071,106)
Total Liabilities and Stockholders’ Deficit 53,140 95,575
Related Party [Member]    
Current Liabilities    
Accounts expenses – related party 938,774 938,774
Accounts payable - related party 911,659 911,659
Short -term advances - related party 1,815,858 1,731,058
Convertible note payable - net of debt discount 173,192 173,192
Notes payable - related party 106,850 106,850
Nonrelated Party [Member]    
Current Liabilities    
Convertible note payable - net of debt discount $ 525,000 $ 525,000